Pancreas regeneration using embryonic pancreatic cells
OwnerPaul Czernichow, Raphael Scharfmanninventors
Life of this patent
Estimating the term…
Abstract
The invention provides a method of regenerating pancreas function in an individual by transplantation of an effective amount of functional pancreatic cells derived from embryonic pancreatic cells not older than 10 weeks of development. Also provided is the method of producing functional animal pancreatic cell. The invention also provides a method of treatment of diabetics. Also are provided pancreatic beta cells as a medicament to treat diabetics.
Claims25
A method of regenerating pancreas function in an individual, the method comprising
- (a) introducing an effective amount of animal embryonic pancreatic cells not older than 10 weeks of development, into the kidney capsule of non-obese diabetic/severe combined immunodeficiency (NOD/scid) animal, excepted human, wherein said NOD/ scid is of a different species than said animal from which are obtained said embryonic pancreatic cells;
- and
- (b) allowing the animal embryonic pancreatic cells to develop, to differentiate and to regenerate at least a pancreatic function;
- and
- (c) transplantation of an effective amount of the animal functional pancreatic cells obtained at step (b), into said individual.
A method of treatment of diabetes in a human patient in need of such treatment, the method comprising the steps of:
- (a) introducing an effective amount of human embryonic pancreatic cells not older than 10 weeks of development, into the kidney capsule of non-obese diabetic/severe combined immunodeficiency (NOD/scid) animal, excepted human;
- and
- (b) allowing the embryonic pancreatic cells to develop, to differentiate and to regenerate at least the pancreatic function;
- and
- (c) transplantation of an effective amount of the human functional pancratic cells obtained at step (b), into said patient,
- (d) and treating diabetics, wherein said treatment is effected by the regeneration of said pancreatic function of regulation of glycemia.
A method of producing functional animal pancreatic cell wherein said method comprises the steps of:
- (a) introducing an effective amount of animal embryonic pancreatic cells not older than 10 weeks of development, into the kidney capsule of non-obese diabetic/severe combined immunodeficiency (NOD/scid) animal, excepted human, wherein said NOD/scid is of a different species than said animal from which are obtained said embryonic pancreatic cells;
- and
- (b) allowing the animal embryonic pancreatic cells to develop, to differentiate and to regenerate at least a pancreatic function;
- and
- (c) collecting animal pancreatic cells obtained at step (b), and
- (d) optionally in vitro culturing the cells obtained at step (c).
- (e)optionally immortalizing the cells obtained at step (d)
A method of producing animal pancreatic cell at different stages of development wherein said method comprises the steps of:
- (a) introducing an effective amount of animal embryonic pancreatic cells not older than 10 weeks of development, into the kidney capsule of non-obese diabetic/severe combined immunodeficiency (NOD/scid) animal, excepted human, wherein said NOD/scid is of a different species than said animal from which are obtained said embryonic pancreatic cells;
- and
- (b) allowing the animal embryonic pancreatic cells to develop, optionally to differentiate and optionally to regenerate at least a pancreatic function;
- and
- (c) collecting animal pancreatic cells obtained at step (b) at different periods of time, and
- (d) optionally in vitro culturing the cells obtained at step (c).
- (e) optionally immortalizing the cells obtained at step (d).
Dependencies are inferred from the claim text.